Rafferty Asset Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $845K | Sell |
|
|||||
|
2025
Q1 | $515K | Sell |
|
|||||
|
2024
Q4 | $769K | Sell |
|
|||||
|
2024
Q3 | $1.02M | Sell |
|
|||||
|
2024
Q2 | $1.1M | Sell |
|
|||||
|
2024
Q1 | $6.29M | Buy |
|
|||||
|
2023
Q4 | $4.91M | Buy |
|
|||||
|
2023
Q3 | $4.24M | Buy |
|
|||||
|
2023
Q2 | $5.25M | Buy |
|
|||||
|
2023
Q1 | $3.79M | Sell |
|
|||||
|
2022
Q4 | $7.21M | Buy |
|
|||||
|
2022
Q3 | $6.14M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $4.22M | Buy |
|
|||||
|
2021
Q4 | $5.29M | Buy |
|